CN104706814A - Circium japonicum-wolfberry health composition - Google Patents
Circium japonicum-wolfberry health composition Download PDFInfo
- Publication number
- CN104706814A CN104706814A CN201310681281.7A CN201310681281A CN104706814A CN 104706814 A CN104706814 A CN 104706814A CN 201310681281 A CN201310681281 A CN 201310681281A CN 104706814 A CN104706814 A CN 104706814A
- Authority
- CN
- China
- Prior art keywords
- radix
- cirsii japonici
- health
- wolfberry health
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Abstract
The invention discloses a circium japonicum-wolfberry health composition. The circium japonicum-wolfberry health composition is prepared from pseudo-ginseng, glossy privet fruit and mulberry. Through careful research and reasonable matching, the circium japonicum-wolfberry health composition can specifically act on organs such as human heart, brain, kidney, lung and liver, has a scientific formula, and utilizes edible traditional Chinese medicines which are safe and nontoxic, can be taken for a long time, have no toxic or side effect and mild drug properties, can improve immunity, can adjust human blood pressure, blood fat and blood sugar, and have health care, prevention and treatment effects on a plurality of common diseases of the human organs.
Description
Technical field
The present invention relates to a kind of Chinese medicine and healthcare field, be specifically related to a kind of Radix Cirsii Japonici Chinese wolfberry health-care compositions.
Background technology
Due to the fast development of modern society, the life-span of people generally extends; Along with, the degree of concern of people to own health also improves constantly, the many factors such as environmental pollution, food pollution, inherited genetic factors are led, operating pressure, infection cause popualtion healthy level to decline, but pursue healthy health and and then longevity be mankind's targets since ancient times, many people are considered as the maximum value of life.How in conjunction with modern medicine, the newest fruits of chemistry to Chinese herbal medicine molecular studies, prepare Chinese medicine composition, the health of enhancement crowd can be safeguarded, correct the chronic disease of the sub-health state of crowd, treatment crowd, long-term taking is free from side effects, playing and illly to cure the disease, illly anosisly all can prolong raw object, is the target of the world of medicine's long-term struggle.
Summary of the invention
The object of the present invention is to provide Chinese holly Radix Cirsii Japonici Chinese wolfberry health-care compositions.
The present invention adopts following technical scheme:
A kind of Radix Cirsii Japonici Chinese wolfberry health-care compositions, is characterized in that being made up of the raw material of following weight portion: Radix Cirsii Japonici 5-15, Radix Salviae Miltiorrhizae 5-15, Radix Notoginseng 5-15, Fructus Lycii 10-30, Fructus Phyllanthi 10-30.
Described Radix Cirsii Japonici Chinese wolfberry health-care compositions, is characterized in that being made up of the raw material of following weight portion: Radix Cirsii Japonici 10-15, Radix Salviae Miltiorrhizae 10-15, Radix Notoginseng 10-15, Fructus Lycii 20-30, Fructus Phyllanthi 10-20.
Described Radix Cirsii Japonici Chinese wolfberry health-care compositions, is characterized in that being made up of the raw material of following weight portion: Radix Cirsii Japonici 7-10, Radix Salviae Miltiorrhizae 5-10, Radix Notoginseng 5-10, Fructus Lycii 10-15, Fructus Phyllanthi 10-30.
Described Radix Cirsii Japonici Chinese wolfberry health-care compositions, is characterized in that being made up of the raw material of following weight portion: Radix Cirsii Japonici 5-9, Radix Salviae Miltiorrhizae 10-15, Radix Notoginseng 5-8, Fructus Lycii 15-30, Fructus Phyllanthi 20-30.
In formula of the present invention, Fructus Phyllanthi is the medicinal plants of health care and disease cure, and its fruit has nearly bimillennial history in China as Chinese medicine among the people.As far back as Han dynasty, raise floating " foreign body will " and special discussion is had to the medical value of emblic.That records in later Tang Materia Medica, " Hainan book on Chinese herbal medicine " is definitely detailed." Chinese medicine voluminous dictionary " is illustrated as " reduce phlegm, give birth to dregs, cough-relieving, detoxify, cure cold heating, cough, pharyngalgia, diphtheria, restlessness and fever with thirst " the medical value of Fructus Phyllanthi.The body-building labor effect that ancient medicine great master Li Shizhen (1518-1593 A.D.) has affirmed fully Fructus Phyllanthi in Compendium of Material Medica to be had " clothes are made light of one's life by commiting suicide for a long time, prolong life long-living ".Tens, whole world country or nationality use Fructus Phyllanthi in the conventional medicament system of oneself.Fructus Phyllanthi have prevent and treat hypertension, hyperlipidemia, defying age, protect the liver, stomach invigorating, beauty treatment, fat-reducing, row's metallic poison, diabetes, the therapeutic efficiency such as anti-various viruses.
Fructus Ligustri Lucidi has hepatoprotective effect.
Radix Salviae Miltiorrhizae, Radix Notoginseng energy blood circulation promoting and blood stasis dispelling, wherein containing there being mutation functional component, can help the cardiovascular and cerebrovascular vessel health of protecting human body.
In the present invention, Radix Cirsii Japonici can by Folium Mahoniae, Rhizoma Coptidis, Echinacea, in the removing pathogenic heat from blood and toxic substance from the body Chinese medicines such as Herba Taraxaci any one or arbitrarily multiple combination to replace or part replaces, Radix Salviae Miltiorrhizae, Radix Notoginseng is replaced by other blood-activating and stasis-removing or part replaces, Fructus Mori, Fructus Lycii, Fructus Ligustri Lucidi can by other as Rhizoma Polygonati, Rhizoma Polygonati Odorati etc. are enriched blood the similar Chinese medicine of yin nourishing, QI invigorating, the mushroom of tonifying YANG Chinese medicine and increase immunity replaces as Lentinus Edodes or part replaces, Fructus Phyllanthi can by Fructus Chebulae, Fructus Terminaliae Billericae, Fructus Canarii replaces or part replaces, when replacing or partly replace, dosage can correspondingly increase, more than replace all belonging to inventive concept, all belong to and invade patent right of the present invention.
The present invention is entirely just through studying intensively, reasonably combined, for each organ such as the heart, brain, kidney, lung, liver of human body, medication all targetedly, and scientific formulation, these Chinese medicines all belong to integration of edible and medicinal herbs food, safety non-toxic, long-term taking, has no side effect, and mild in medicine property and, can immunity be promoted, suppress and eliminate virus and bacteriological infection, regulating human blood-pressure, blood glucose, blood fat, to the existing health care preventive effect of the multiple common disease of each organ of crowd, also there is certain therapeutical effect.
Detailed description of the invention
Embodiment 1:
Fructus Lycii mulberry health-care compositions of the present invention, is made up of the raw material of following weight portion (gram): Radix Cirsii Japonici 9, Radix Salviae Miltiorrhizae 15, Radix Notoginseng 5, Fructus Lycii 30, Fructus Phyllanthi 20.
In above formula, Echinacea 1-10 gram that following weight portion can be increased or/and Radix Ginseng 1-10 gram, by enhancing immunity, to increase curative effect.
Decocting potion every day, also can make other dosage form.
One, zoopery functional effect checking of the present invention:
Carry out safety poison by Ministry of Public Health " health food inspection and assessment technical specification " (version in 2003) evaluation methodology and learn evaluation test, result is as follows:
(1) acute oral toxicity test: the maximum tolerated dose (MTD) of sample to male and female white mice is all greater than 20000mg/kg;
(2) three genetic toxicity tests: mice bone marrow micronucleus, sperm malformation test, Ames result of the test are feminine gender;
(3) 30 days feeding trials: experimental session, experimental animal growing state is good, each dosage group body weight, weightening finish, food utilization, routine blood indexes, blood biochemistry index, organ weights and internal organs/body weight ratio and histological indications compared with matched group, equal no significant difference.
Safety toxicology result of the test show sample safety non-toxic.
Get the powder in the embodiment of the present invention 1, according to the evaluation methodology of " health food inspection and assessment technical specification " (version in 2003), carry out animal function test, this sample has enhancing cellular immune function, strengthens body fluid immunity function.
Two, water extract of the present invention, for crowd treat checking as follows:
Grandson, man, 46 years old, closely feel thirsty, polydipsia over the past half year, health is become thin gradually, tired out, drowsiness, measure fasting glucose 11.6 mmol/l, two hours blood glucoses are 14.5 mmol/l after meal, dose a patient with medicine of the present invention, every day potion, every agent liquid medicine decocts twice, taking January is a course for the treatment of, after two months, survey its fasting glucose 6.1 mmol/l, 2 hours blood glucoses are 8.6 mmol/l after meal.Allow its following the service bimester with consolidate curative effect.
Lin, female, 59 years old, nearly half a year, somatosensory was tired, lost weight, companion's poor appetite, irritated, insomnia, and dry stool sometimes, the dark tongue of light red tongue is white, deep and hesitant pulse.Fasting glucose time medical: fasting glucose 12.3 mmol/l, two hours blood glucoses are 15.5 mmol/l after meal, dose a patient with medicine of the present invention, every day potion, every agent liquid medicine decocts twice, and taking January is a course for the treatment of, after two months, survey its fasting glucose 6.4 mmol/l, 2 hours blood glucoses are 8.8mmol/l after meal.Allow its following the service bimester with consolidate curative effect.
Wang, female, 65 years old, nearly half a year, somatosensory was tired, lost weight, companion's poor appetite, agitation, insomnia, fasting glucose time medical: fasting glucose 11.3 mmol/l, two hours blood glucoses are 13.8 mmol/l after meal, and dose a patient with medicine of the present invention, every day potion, every agent liquid medicine decocts twice, and taking January is a course for the treatment of, after two months, survey its fasting glucose 6.0 mmol/l, 2 hours blood glucoses are 8.1mmol/l after meal.Allow its following the service bimester with consolidate curative effect.
Lee, female, 45 years old, suffers from hypertension 8 years, blood pressure high pressure 150 millimeters of high mercury column at ordinary times, low pressure 100 millimeters of high mercury column.Take hypertension pill normal after, drug withdrawal rebounds rising immediately.Use medicine of the present invention, after taking 2 months, the normal 130/90mmHg of Measure blood pressure, drug withdrawal after one month Measure blood pressure still without rising, recover.
Zhang, female, 56 years old, suffers from hypertension 4 years, blood pressure high pressure 155 millimeters of high mercury column at ordinary times, low pressure 110 millimeters of high mercury column.Take hypertension pill normal after, drug withdrawal rebounds rising immediately.Use medicine of the present invention, after taking 2 months, the normal 125/95mmHg of Measure blood pressure, drug withdrawal after one month Measure blood pressure still without rising, recover.
Wang, female, 65 years old, suffers from hypertension 10 years, blood pressure high pressure 160 millimeters of high mercury column at ordinary times, low pressure 110 millimeters of high mercury column.Take hypertension pill normal after, drug withdrawal rebounds rising immediately.Use medicine of the present invention, after taking 2 months, the normal 140/95mmHg of Measure blood pressure, drug withdrawal after one month Measure blood pressure still without rising, recover.
In certain, man, 84 years old, I was fat, dizzy distending pain all day, and body is stranded limb acid, and heavy fiber crops are unable, and health check-up blood pressure 150/110 mmHg, blood fat are high.With drug administration of the present invention 5 months, health was normal, all transference cures.Check that blood pressure, blood fat are all normal.
Lin, man, 28 years old, hepatitis B, was detected as great three positive, the course of disease 15 years, and liver function is normal, and in many ways seek medical advice, invalid, take medicine of the present invention, day takes potion, and within 6 months, detect, be small three positive, liver function is normal.
Zhao, female, 32 years old, hepatitis B, was detected as small three positive, the course of disease 18 years, and liver function is normal, and in many ways seek medical advice, invalid, take medicine of the present invention, day takes potion, within 6 months, detected, and five indices is negative entirely, and liver function is normal; Following the service medicine of the present invention 6 months, surface antibody is positive, recovery from illness.
Week certain, man 38 years old, hepatitis B, is detected as great three positive, the course of disease 11 years, normal during liver function, time and irregular variation is large, in many ways seek medical advice, invalid, take medicine of the present invention, take potion day, within 6 months, detect, be small three positive, liver function is normal.
Claims (5)
1. a Radix Cirsii Japonici Chinese wolfberry health-care compositions, is characterized in that being made up of the raw material of following weight portion: Radix Cirsii Japonici 5-15, Radix Salviae Miltiorrhizae 5-15, Radix Notoginseng 5-15, Fructus Lycii 10-30, Fructus Phyllanthi 10-30.
2. Radix Cirsii Japonici Chinese wolfberry health-care compositions according to claim 1, is characterized in that being made up of the raw material of following weight portion: Radix Cirsii Japonici 10-15, Radix Salviae Miltiorrhizae 10-15, Radix Notoginseng 10-15, Fructus Lycii 20-30, Fructus Phyllanthi 10-20.
3. Radix Cirsii Japonici Chinese wolfberry health-care compositions according to claim 1, is characterized in that being made up of the raw material of following weight portion: Radix Cirsii Japonici 7-10, Radix Salviae Miltiorrhizae 5-10, Radix Notoginseng 5-10, Fructus Lycii 10-15, Fructus Phyllanthi 10-30.
4. Radix Cirsii Japonici Chinese wolfberry health-care compositions according to claim 1, is characterized in that being made up of the raw material of following weight portion: Radix Cirsii Japonici 5-9, Radix Salviae Miltiorrhizae 10-15, Radix Notoginseng 5-8, Fructus Lycii 15-30, Fructus Phyllanthi 20-30.
5., according to the health composition one of claim 1-4 Suo Shu, it is characterized in that the Echinacea 1-10 wherein also containing following weight portion is or/and Radix Ginseng 1-10.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310681281.7A CN104706814A (en) | 2013-12-16 | 2013-12-16 | Circium japonicum-wolfberry health composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310681281.7A CN104706814A (en) | 2013-12-16 | 2013-12-16 | Circium japonicum-wolfberry health composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104706814A true CN104706814A (en) | 2015-06-17 |
Family
ID=53406858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310681281.7A Withdrawn CN104706814A (en) | 2013-12-16 | 2013-12-16 | Circium japonicum-wolfberry health composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104706814A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1628786A (en) * | 2004-08-30 | 2005-06-22 | 广东药学院 | Medicine for treating hyperlipemia |
CN1704085A (en) * | 2004-06-04 | 2005-12-07 | 成都地奥制药集团有限公司 | Pharmaceutical composition with immunoregulation function and method for preparing the same |
CN1742927A (en) * | 2005-09-17 | 2006-03-08 | 张志祥 | Medicinal tablet made from fruit of Chinese wolfberry and spica Mori and its preparing process |
-
2013
- 2013-12-16 CN CN201310681281.7A patent/CN104706814A/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1704085A (en) * | 2004-06-04 | 2005-12-07 | 成都地奥制药集团有限公司 | Pharmaceutical composition with immunoregulation function and method for preparing the same |
CN1628786A (en) * | 2004-08-30 | 2005-06-22 | 广东药学院 | Medicine for treating hyperlipemia |
CN1742927A (en) * | 2005-09-17 | 2006-03-08 | 张志祥 | Medicinal tablet made from fruit of Chinese wolfberry and spica Mori and its preparing process |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103789177B (en) | A kind of supplementing QI and nourishing YIN compound Taizi ginsen health promoting wine | |
CN104706707A (en) | Antiviral immunity-enhancing ginseng healthcare product | |
CN102038758A (en) | Rheumatism preparation used for treating rheumatism | |
CN101670011A (en) | Medicament for treating rheumatism and rheumatoid and preparation method thereof | |
CN101293065B (en) | Biological proprietary Chinese medicine for preventing and treating diabetes | |
CN101444617A (en) | Traditional Chinese medicine formula for oral administration used for treating arrhythmia | |
CN100423754C (en) | Medicine for treating chronic alcoholic hepatopathy and its preparing method | |
CN104706813A (en) | Mulberry-glossy privet fruit health composition | |
CN104687032A (en) | Health caring echinacea health product | |
CN104705634A (en) | Lucid ganoderma healthcare product for protecting health | |
CN104740079A (en) | Phyllanthus emblica health-care traditional Chinese medicine composition | |
CN107837384A (en) | A kind of Chinese medicine composition for treating hand-foot-and-mouth disease | |
CN104706815A (en) | Wolfberry-pseudo-ginseng health composition | |
CN102488825B (en) | Traditional Chinese medicine composition for treating beriberoid pyretic arthralgia and application of traditional Chinese medicine composition | |
CN104705637A (en) | A Chinese wolfberry and mulberry health-care combination | |
CN102727765B (en) | Internally-used medicine for treating aplastic anemia by nourishing yin and yang | |
CN102319387B (en) | Traditional Chinese medicine composition for treating chronic cough | |
CN104706814A (en) | Circium japonicum-wolfberry health composition | |
CN104706734A (en) | Circium japonicum-pseudo-ginseng health composition | |
CN104758578A (en) | Traditional Chinese medicine composition for treating palpitation | |
CN104353039A (en) | Chinese medicinal composition for treating wind-cold type common cold | |
CN103989954A (en) | Traditional Chinese medicine preparation for treating iron-deficiency anemia | |
CN103301368A (en) | Medicament for treating hyperactivity | |
CN103550335A (en) | Traditional Chinese medicinal composition for improving liver function | |
CN104706817A (en) | Health enhancing traditional Chinese medicine composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20150617 |
|
WW01 | Invention patent application withdrawn after publication |